The Brain Science Foundation’s research portfolio boasts some of the most innovative science related to brain tumors as well as collaborative projects that promise to accelerate the translation of this science into clinical treatments and personalized therapies. The BSF’s growing research team consists of the world’s most gifted neuroscientists who are providing the very best patient treatment and care.

  • Meningioma Clinical Trial Initiated

    Thursday, June 1st, 2017
    The BSF is proud to support a new set of clinical initiatives that hold great promise in the area of Meningioma treatment. Using BSF funds, investigators: Priscilla Brastianos, MD;...
    Read More

  • Nivolumab Clinical Trial

    Sunday, May 28th, 2017
    The first immunotherapy trial to investigate the role of immune checkpoint blockade for meningioma tumors is currently underway. Our group at the Dana-Farber Cancer Institute/Brigham and Women’s Hospital studied...
    Read More